Dymista Nasal Spray 1,0 mg and 0,365 mg Suspension
PDF Leaflet Revision Date: 31 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of seasonal and perennial allergic rhinitis and rhino-conjunctivitis.
Dosage (summary)
One actuation in each nostril twice daily for adults and children 6 years and older.
Onset of Action / Duration
Onset: 15 mins, Duration: long-term use.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Limited data; caution advised during pregnancy and lactation.
Key Drug Interactions
- Ritonavir
- Ketoconazole
- Alcohol
Contraindications
- Hypersensitivity to azelastine or fluticasone
Common side effects
- Dysgeusia
- Epistaxis
- Headache
Counselling Points
- Avoid contact with eyes
- Monitor for signs of infection
- Caution with activities requiring alertness
Serious warnings
- Somnolence
- Potential for glaucoma and cataracts
- Immunosuppression
Important Disclaimer
The Dymista Nasal Spray 1,0 mg and 0,365 mg Suspension professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
